1 - 25 of 3
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Development of a Retinal Ganglion Cell Specific Gene Therapy Using SIRT1 Signaling for Neuro-Protection (Video)Ahmara G. Ross, Devin McDougald, Reas Khan, Thu Duong, Kimberly Dine, Puya Aravand, Natalia Tavares, Jean Bennett, Kenneth ShindlerLoss of retinal ganglion cells (RGC) can occur by trauma, inflammatory, and ischemia leading to irreversible effects upon vision. Sirtuin 1 (SIRT1) deacetylase has demonstrated therapeutic value in multiple models of optic neuropathy with small molecule biologics. The initial use of gene therapy...20200310_nanos_sciplatform3_04
2 Development of a Retinal Ganglion Cell Specific Gene Therapy Using SIRT1 Signaling for Neuro-Protection (Slides)Ahmara G. Ross, Devin McDougald, Reas Khan, Thu Duong, Kimberly Dine, Puya Aravand, Natalia Tavares, Jean Bennett, Kenneth ShindlerLoss of retinal ganglion cells (RGC) can occur by trauma, inflammatory, and ischemia leading to irreversible effects upon vision. Sirtuin 1 (SIRT1) deacetylase has demonstrated therapeutic value in multiple models of optic neuropathy with small molecule biologics. The initial use of gene therapy...20200310_nanos_sciplatform3_04-slides
3 Development of a Retinal Ganglion Cell Specific Gene Therapy Using SIRT1 Signaling for Neuro-Protection (PDF)Ahmara G. Ross, Devin McDougald, Reas Khan, Thu Duong, Kimberly Dine, Puya Aravand, Natalia Tavares, Jean Bennett, Kenneth ShindlerLoss of retinal ganglion cells (RGC) can occur by trauma, inflammatory, and ischemia leading to irreversible effects upon vision. Sirtuin 1 (SIRT1) deacetylase has demonstrated therapeutic value in multiple models of optic neuropathy with small molecule biologics. The initial use of gene therapy...20200310_nanos_sciplatform3_04-pdf
1 - 25 of 3